semaglutide insurance coverage Coverage, Type of Employment Shape Inequities in Access to Semaglutide Insurance Coverage for Weight

If you would like to find out more about how Solice Health can help you on your health journey, we encourage you to get in touch

USE OF GLP-1 RECEPTOR AGONISTS IN PEDIATRIC OBESITY AND MASLD As of 2025, the Food and Drug Administration (FDA) has approved a few GLP-1 receptor agonists for use in pediatric populations with several others under active investigation

We have to be able to get to patients in an affordable way. Zepbound, manufactured by pharmaceutical company Eli Lilly, is part of the same class of drugs, GLP-1 agonists, as Ozempic and Wegovy, which have gained popularity for their ability to induce weight loss quickly

Peikert et al., 2025